- Home
- OCFT vs OBIO Comparison
OCFT vs OBIO Comparison
Compare OCFT & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- OBIO
- Stock Information
- Founded
- OCFT 2015
- OBIO 2017
- Country
- OCFT China
- OBIO United States
- Employees
- OCFT N/A
- OBIO N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- OCFT Technology
- OBIO Health Care
- Exchange
- OCFT Nasdaq
- OBIO Nasdaq
- Market Cap
- OCFT 169.6M
- OBIO 151.3M
- IPO Year
- OCFT 2019
- OBIO N/A
- Fundamental
- Price
- OCFT $6.07
- OBIO $2.85
- Analyst Decision
- OCFT
- OBIO Strong Buy
- Analyst Count
- OCFT 0
- OBIO 5
- Target Price
- OCFT N/A
- OBIO $15.00
- AVG Volume (30 Days)
- OCFT 77.6K
- OBIO 69.1K
- Earning Date
- OCFT 05-20-2025
- OBIO 05-12-2025
- Dividend Yield
- OCFT N/A
- OBIO N/A
- EPS Growth
- OCFT N/A
- OBIO N/A
- EPS
- OCFT N/A
- OBIO N/A
- Revenue
- OCFT $307,997,287.00
- OBIO $2,638,000.00
- Revenue This Year
- OCFT N/A
- OBIO $27.37
- Revenue Next Year
- OCFT $6.37
- OBIO $42.68
- P/E Ratio
- OCFT N/A
- OBIO N/A
- Revenue Growth
- OCFT N/A
- OBIO N/A
- 52 Week Low
- OCFT $0.87
- OBIO $2.49
- 52 Week High
- OCFT $6.90
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- OCFT 49.29
- OBIO 36.86
- Support Level
- OCFT $5.40
- OBIO $2.75
- Resistance Level
- OCFT $6.45
- OBIO $3.26
- Average True Range (ATR)
- OCFT 0.33
- OBIO 0.48
- MACD
- OCFT -0.10
- OBIO -0.01
- Stochastic Oscillator
- OCFT 47.86
- OBIO 16.82
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.